These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38185904)

  • 1. PAX2 is regulated by estrogen/progesterone through promoter methylation in endometrioid adenocarcinoma and has an important role in carcinogenesis via the AKT/mTOR signaling pathway.
    Chen H; Li L; Liu H; Qin P; Chen R; Liu S; Xiong H; Li Y; Yang Z; Xie M; Yang H; Jiang Q
    J Pathol; 2024 Apr; 262(4):467-479. PubMed ID: 38185904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
    Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
    Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPF1 impacts on mTOR signaling pathway and autophagy in endometrioid endometrial carcinoma.
    Zhang M; Chen H; Qin P; Cai T; Li L; Chen R; Liu S; Chen H; Lin W; Chen H; Strickland AL; Xiong H; Jiang Q
    Aging (Albany NY); 2021 Sep; 13(17):21202-21215. PubMed ID: 34520393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating
    Huang C; Hu G
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29449346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.
    Chen R; Zhang M; Liu W; Chen H; Cai T; Xiong H; Sheng X; Liu S; Peng J; Wang F; Chen H; Lin W; Xu X; Zheng W; Jiang Q
    Cell Death Dis; 2018 Dec; 10(1):4. PubMed ID: 30584245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
    Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
    Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.
    Jia N; Wang J; Li Q; Tao X; Chang K; Hua K; Yu Y; Wong KK; Feng W
    Oncotarget; 2016 Dec; 7(51):84785-84797. PubMed ID: 27764784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retained PAX2 expression associated with DNA mismatch repair deficiency in endometrial endometrioid adenocarcinoma.
    X Zhang G; Yang B
    Histopathology; 2024 Nov; 85(5):794-803. PubMed ID: 39075663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
    Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
    Wu D; Huang HJ; He CN; Wang KY
    Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lnc-NA inhibits proliferation and metastasis in endometrioid endometrial carcinoma through regulation of NR4A1.
    Sun L; Zhou R; Dong J; Liu S; Jiao Y; Wang L; Hu S; He P; Liu X; Zhao X; Jiang G; Zhao Y
    J Cell Mol Med; 2019 Jul; 23(7):4699-4710. PubMed ID: 31050196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
    Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
    He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
    Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia.
    Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH
    Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway.
    Wu W; Chen X; Liu X; Bao HJ; Li QH; Xian JY; Lu BF; Zhao Y; Chen S
    Mol Carcinog; 2023 Apr; 62(4):413-426. PubMed ID: 36562475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
    Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.